[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350292-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350292-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","multi-omic-analysis-of-glioma-identifies-rrm2-as-a-prognostic-biomarker-associated-with-tumor-stemness-and-cell-cyclerelated-pathways-research-summary","Multi-Omic Analysis of Glioma Identifies RRM2 as a Prognostic Biomarker Associated With Tumor Stemness and Cell Cycle–Related Pathways - Research Summary","","Retrospective multi-omic analyses integrate TCGA, TARGET, and GTEx to define RRM2 expression patterns and clinical relevance across 34 solid tumor types, followed by focused glioma (GBMLGG) assessment of links to MATH, stemness indices, clinicopathological features, and survival. Differential expression with KEGG and GSEA, plus GSEA, evaluates RRM2-associated biological pathways. RRM2 shows pan-cancer upregulation, strongest prognostic impact in GBMLGG, higher expression than normal brain, high diagnostic accuracy, and correlations with stemness and cell cycle and immune-related processes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/multi-omic-analysis-of-glioma-identifies-rrm2-as-a-prognostic-biomarker-associated-with-tumor-stemness-and-cell-cyclerelated-pathways-research-summary/350292/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/multi-omic-analysis-of-glioma-identifies-rrm2-as-a-prognostic-biomarker-associated-with-tumor-stemness-and-cell-cyclerelated-pathways-research-summary/350292.png","ImageObject",300,407,{"name":42,"@type":43},"Chumphorn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How was RRM2 evaluated across cancers and specifically in glioma?","Question",{"text":63,"@type":64},"The study integrated TCGA, TARGET, and GTEx to profile RRM2 expression and prognostic relevance across 34 solid tumor types. Glioma (GBMLGG) was then analyzed for associations with MATH, stemness indices, clinicopathological variables, and survival outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What clinical and diagnostic performance did RRM2 show in glioma?",{"text":68,"@type":64},"RRM2 was markedly higher in glioma than in normal brain tissue and achieved high diagnostic accuracy (AUC = 0.967). Elevated RRM2 was linked to advanced age, higher WHO grade, IDH wild-type status, and worse overall survival, disease-specific survival, and progression-free interval.",{"name":70,"@type":61,"acceptedAnswer":71},"How were RRM2-related pathways and biological features investigated?",{"text":72,"@type":64},"Differential expression was combined with KEGG analysis and Gene Set Enrichment Analysis (GSEA) to explore RRM2-associated pathways. RRM2 expression was positively correlated with tumor stemness, negatively correlated with intratumoral heterogeneity, and associated with cell cycle and immune-related pathway enrichment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350292,1790270072,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336475401981,"https://ap-avatar.wpscdn.com/avatar/22000c94efd8d5204d?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786935347598174694","Multi-Omic Analysis of Glioma Identifies RRM2 as a Prognostic Biomarker Associated With Tumor Stemness and Cell Cycle–Related Pathways  \nTechnology in Cancer Research & Treatment Volume 25: 1–13 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)  \n[DOI: 10.1177/15330338261453490](DOI: 10.1177/15330338261453490)  \n[journals.sagepub.com/home/tct](journals.sagepub.com/home/tct)  \nJiayuan Li1,*, Liubing Hou1,2,*, Xuetao Han1,*, Yu Wang1, Xiang Zhan1, Zizhou Zhang1, Ge Zhang1, Mengting Zhang4, Weijing Cai1,5, Huandi Zhou1,2,3, and Xiaoying Xue1,3  \nAbstract  \nIntroduction: Glioma is the most common primary malignant tumor of the central nervous system and remains associated with poor prognosis and limited effective biomarkers. Ribonucleotide reductase M2 (RRM2), a key enzyme involved in DNA synthesis, is frequently upregulated in multiple cancers; however, its pan-cancer characteristics and clinical significance in glioma remain incompletely defined. Methods: This retrospective study integrated data from The Cancer Genome Atlas (TCGA), Therapeutically Applicable Research to Generate Effective Treatments (TARGET), and Genotype-Tissue Expression (GTEx) to characterize RRM2 expression patterns and prognostic relevance across 34 solid tumor types. Glioma (GBMLGG) was further analyzed to assess associations between RRM2 expression and Mutant-Allele Tumor Heterogeneity (MATH), stemness indices, clinicopathological features, and survival outcomes. An RRM2-based prognostic nomogram was constructed and externally validated. Differential expression analysis combined with Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Set Enrichment Analysis (GSEA) was performed to explore RRM2-associated biological pathways. Results: RRM2 was significantly upregulated in 33 of 34 cancer types, with the strongest prognostic effect observed in GBMLGG. In glioma, RRM2 expression was markedly higher than in normal brain tissue (P \u003C 0.001) and showed high diagnostic accuracy (AUC = 0.967) . Elevated RRM2 expression was associated with advanced age, higher WHO grade, and Isocitrate Dehydrogenase (IDH) wild-type status, and predicted significantly poorer overall survival, disease-specific survival, and progression-free interval (all P \u003C 0.001) . A nomogram incorporating RRM2 expression, age, WHO grade, and IDH status demonstrated robust predictive performance for 1-, 3-, and 5-year survival. RRM2 expression was positively correlated with tumor stemness and negatively correlated with intratumoral heterogeneity, and was associated with enrichment of cell cycle and immune-related pathways. Conclusion: RRM2 is markedly overexpressed in glioma and is strongly associated with  \n1Department of Radiotherapy, The Second Hospital of Hebei Medical University, Shijiazhuang, China 2Department of Central Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang, China  \n3Hebei Key Laboratory of Etiology Tracing and Individualized Diagnosis and Treatment for Digestive System Carcinoma, The Second Hospital of Hebei Medical University, Shijiazhuang, China  \n4Department of Oncology, Handan Central Hospital, Handan, China 5Department of Emergency, The second hospital of Bazhou, Bazhou, China  \n*Jiayuan Li, Liubing Hou and Xuetao Han contributed equally to this work.  \nCorresponding authors:  \nXiaoying Xue, Department of Radiotherapy, The Second Hospital of Hebei Medical University, No.215 Heping West Road, Shijiazhuang, Hebei 050000, P.R. China.  \nEmail: [xxy0636@hebmu.edu.cn](xxy0636@hebmu.edu.cn)  \nHuandi Zhou, Department of Radiotherapy, The Second Hospital of Hebei Medical University, No.215 Heping West Road, Shijiazhuang, Hebei 050000, P.R. China.  \nEmail: [huandizhou@hebmu.edu.cn](huandizhou@hebmu.edu.cn)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativecommons.org/lic","cbCaiuwuLToJKjny","https://ap.wps.com/l/cbCaiuwuLToJKjny","pdf",2867216,13,"English","# Abstract\n# Introduction\n## Rationale and background\n# Methods\n# Results\n## Expression, diagnostic accuracy, and survival\n## Nomogram and pathway enrichment","[{\"question\":\"How was RRM2 evaluated across cancers and specifically in glioma?\",\"answer\":\"The study integrated TCGA, TARGET, and GTEx to profile RRM2 expression and prognostic relevance across 34 solid tumor types. Glioma (GBMLGG) was then analyzed for associations with MATH, stemness indices, clinicopathological variables, and survival outcomes.\"},{\"question\":\"What clinical and diagnostic performance did RRM2 show in glioma?\",\"answer\":\"RRM2 was markedly higher in glioma than in normal brain tissue and achieved high diagnostic accuracy (AUC = 0.967). Elevated RRM2 was linked to advanced age, higher WHO grade, IDH wild-type status, and worse overall survival, disease-specific survival, and progression-free interval.\"},{\"question\":\"How were RRM2-related pathways and biological features investigated?\",\"answer\":\"Differential expression was combined with KEGG analysis and Gene Set Enrichment Analysis (GSEA) to explore RRM2-associated pathways. RRM2 expression was positively correlated with tumor stemness, negatively correlated with intratumoral heterogeneity, and associated with cell cycle and immune-related pathway enrichment.\"}]","Multi-Omic Analysis of Glioma Identifies RRM2 as a Prognostic Biomarker Associated With Tumor Stemness and Cell Cycle–Related Pathways - Research Summary | PDF",1790088267,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ac0c9bb0f896ac0d2aab4481fe9eb5d.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49533f57c44c6f93919c5784cb525562.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b7db687ddefa953bf48270711c0eb72.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2753f4bcab83e896415500863bcf7cf2.webp",980,1306]